Mackie Research Capital analyst Venkata Velagapudi downgraded Khiron Life Sciences to Hold from Speculative Buy with a C$0.10 price target.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on KHRNF:
Mackie Research Capital analyst Venkata Velagapudi downgraded Khiron Life Sciences to Hold from Speculative Buy with a C$0.10 price target.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on KHRNF: